Jiangsu-based Sanpower has acquired Dendreon, a Seattle-based maker of the prostate cancer vaccine Provenge, from Canada's Valeant Pharmaceuticals International for $820 million. Yuan Yafei, chairman of Sanpower, flew from Nanjing …